Open AccessEffects of Intraduodenal Infusion of the Bitter Tastant, Quinine, on Antropyloroduodenal Motility, Plasma Cholecystokinin, and Energy Intake in Healthy Men
Author(s) -
Vida Bitarafan,
Penelope C. E. Fitzgerald,
Tanya J. Little,
Wolfgang Meyerhof,
Tongzhi Wu,
Michael Horowitz,
Christine FeinleBisset
Publication year - 2019
Publication title -
journal of neurogastroenterology and motility
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.345
H-Index - 42
eISSN - 2093-0887
pISSN - 2093-0879
DOI - 10.5056/jnm19036
Subject(s) - medicine , cholecystokinin , quinine , motility , endocrinology , anesthesia , pharmacology , malaria , immunology , receptor , biology , genetics
Quinine, administered intraduodenally over 60 minutes, even at moderately high doses, but low infusion rates, does not modulate appetite-related gastrointestinal functions or energy intake.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom